Showing results (341-350 of 642) with videos related to
Sort By:
Pageof 65
Nursing Administration Quarterly|December 2, 2017
The CNO and Leading Innovation: Competencies for the FutureBarbara Weatherford, Kathleen A Bower, Joan Vitello-CicciuJournal of Medicinal Chemistry|May 5, 2000
Design and synthesis of conformationally constrained glucagon analoguesD Trivedi, Y Lin, J M Ahn, et al.Peptides|March 1, 1989
The effects of structure-conformation modifications of melanotropin analogs on learning and memory: D-amino acid substituted linear and cyclic analogsB E Beckwith, T P Tinius, V J Hruby, et al.Pharmaceutical Research|July 11, 2000
Pharmacologic response of a controlled-release PLGA formulation for the alpha-melanocyte stimulating hormone analog, Melanotan-IR Bhardwaj, M E Hadley, R T Dorr, et al.European Journal of Pharmacology|June 9, 1998
Endomorphin-1 and endomorphin-2 are partial agonists at the human mu-opioid receptorK Hosohata, T H Burkey, J Alfaro-Lopez, et al.Pigment Cell Research|November 1, 1992
Effects of a melanotropic peptide on melanoma cell growth, metastasis, and invasionK R Gehlsen, M E Hadley, N Levine, et al.Drug Design and Discovery|December 1, 1996
Three-dimensional molecular models of the hMC1R melanocortin receptor: complexes with melanotropin peptide agonistsC Haskell-Luevano, T K Sawyer, S Trumpp-Kallmeyer, et al.The Journal of Pharmacology and Experimental Therapeutics|October 1, 1985
Light microscopic autoradiographic localization of somatostatin receptors in the rat brainK Gulya, J K Wamsley, D Gehlert, et al.Life Sciences|May 30, 1983
Conformationally constrained cyclic enkephalin analogs with pronounced delta opioid receptor agonist selectivityH I Mosberg, R Hurst, V J Hruby, et al.International Journal of Peptide and Protein Research|June 1, 1988
Cholecystokinic activity of N alpha-hydroxysulfonyl-[Nle28,31]CCK26-33 analogues modified at the C-terminal residueE E Sugg, M Serra, J E Shook, et al.Pageof 65